Literature DB >> 31385233

Pancreatic Cancer in Iran: an Epidemiological Review.

Fatemeh Hadavand Siri1, Hamid Salehiniya2,3.   

Abstract

PURPOSE: Pancreatic cancer is the seventh cause of death in men in the world and also is one of the most common malignancies worldwide with poor prognosis. Due to the lack of epidemiological aspects of pancreatic cancer in Iran, this study aimed to investigate the epidemiological aspects of pancreatic cancer in Iran.
METHODS: In February 2019, A search was conducted with the keywords "Pancreatic Neoplasm," "Pancreas Neoplasms," "Cancer of Pancreas," "Pancreas Cancer," "Pancreatic Cancer," "Cancer of the Pancreas," and "Iran" in their title or abstract and MeSH. The databases of Medline, Web of Science, Scopus, SID, IranMedex, and Google Scholar were searched. The title and abstract of the papers were reviewed, and articles that addressed the epidemiological aspects of pancreatic cancer were included; in total, 20 full papers were reviewed.
RESULTS: According to studies, the incidence and mortality rate of pancreatic cancer is steadily increasing with age. Actually, men are more likely to develop this carcinoma than women. Smoking, aging, and lifestyle changes are the most important risk factors for pancreatic cancer in Iran. Due to the lack of initial symptoms or a specific marker for early diagnosis of pancreatic cancer, this cancer is detected lately and therefore low survival rate is observed.
CONCLUSION: Mortality and incidence of pancreatic cancer is increasing in Iran. Pancreatic cancer is more common in men than women. Based on the results of this study, pancreatic cancer depends largely on the lifestyle. Survival of pancreatic cancer is low in untreated patients.

Entities:  

Keywords:  Epidemiology; Incidence; Mortality and Iran; Pancreatic cancer; Risk factor

Mesh:

Year:  2020        PMID: 31385233     DOI: 10.1007/s12029-019-00279-w

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  4 in total

1.  The IGSF1, Wnt5a, FGF14, and ITPR1 Gene Expression and Prognosis Hallmark of Prostate Cancer.

Authors:  Sheida Ebrahimi; Fariba Rezaei Fakhrnezhad; Sanaz Jahangiri; Mahdis Borjkhani; Rosa Behboodi; Amir Monfaredan
Journal:  Rep Biochem Mol Biol       Date:  2022-04

2.  Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.

Authors:  Mahdi Sheikh; Sahar Masoudi; Razieh Bakhshandeh; Alireza Moayyedkazemi; Farhad Zamani; Sepideh Nikfam; Masoumeh Mansouri; Neda Ghamarzad Shishavan; Saman Nikeghbalian; Paul Brennan; Reza Malekzadeh; Akram Pourshams
Journal:  PLoS One       Date:  2020-12-04       Impact factor: 3.240

3.  Predictors of survival rate in patients with pancreatic cancer: A multi-center analytical study in Iran.

Authors:  Mansour Bahardoust; Mohammad Ali Abyazi; Sayed Ali Emami; Parmida Ghadimi; Mehrdad Khodabandeh; Farhad Mahmoudi; Ramin Hosseinzadeh; Mohammad Heiat; Shahram Agah
Journal:  Cancer Rep (Hoboken)       Date:  2021-09-07

4.  Dietary intake of fatty acids and risk of pancreatic cancer: Golestan cohort study.

Authors:  Azita Hekmatdoost; Akram Pourshams; Neda Ghamarzad Shishavan; Sahar Masoudi; Ashraf Mohamadkhani; Sadaf G Sepanlou; Maryam Sharafkhah; Hossein Poustchi; Mehdi Mohamadnejad
Journal:  Nutr J       Date:  2021-07-16       Impact factor: 3.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.